Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 28.33 USD -0.87%
Market Cap: 568.6m USD
Have any thoughts about
Simulations Plus Inc?
Write Note

Simulations Plus Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Simulations Plus Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Simulations Plus Inc
NASDAQ:SLP
Accounts Receivables
$15m
CAGR 3-Years
5%
CAGR 5-Years
13%
CAGR 10-Years
24%
Veeva Systems Inc
NYSE:VEEV
Accounts Receivables
$301.3m
CAGR 3-Years
3%
CAGR 5-Years
15%
CAGR 10-Years
21%
Inspire Medical Systems Inc
NYSE:INSP
Accounts Receivables
$89.7m
CAGR 3-Years
50%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Accounts Receivables
$107.4m
CAGR 3-Years
29%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Accounts Receivables
$251.8m
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
10%
W
Waystar Holding Corp
NASDAQ:WAY
Accounts Receivables
$126.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Simulations Plus Inc
Glance View

Market Cap
568m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
19.62 USD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Simulations Plus Inc's Accounts Receivables?
Accounts Receivables
15m USD

Based on the financial report for Aug 31, 2024, Simulations Plus Inc's Accounts Receivables amounts to 15m USD.

What is Simulations Plus Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
24%

Over the last year, the Accounts Receivables growth was 47%. The average annual Accounts Receivables growth rates for Simulations Plus Inc have been 5% over the past three years , 13% over the past five years , and 24% over the past ten years .

Back to Top